Drug Profile
Ruzasvir/uprifosbuvir - Merck & Co
Alternative Names: MK 3682CLatest Information Update: 07 Dec 2017
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Antivirals; Benzoxazines; Carbamates; Cyclopropanes; Esters; Imidazoles; Pyrrolidines; Thiazoles; Uracil nucleotides
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis C